Browse the complete record of transactions filed by Cui Xiangmin. Director active across 3 companies, notably ALPINE IMMUNE SCIENCES, INC.. Cumulatively, 4 filings have been logged. Total volume traded: €24.6m. The latest transaction was filed on 17 September 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.